Keith Crandell

Insider Reports History

Entity
Individual
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Signature
/s/ Dennis Cho, as Attorney-in-Fact for Keith Crandell
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Crandell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sana Biotechnology, Inc. 10%+ Owner Common Stock 12.4M $68.5M $5.50 Feb 8, 2024 Indirect
908 Devices Inc. Director, 10%+ Owner Common Stock 5.73M $36.8M $6.42 Jun 12, 2024 Indirect
DA32 Life Science Tech Acquisition Corp. Director, 10%+ Owner Class A Common Stock 650K $6.5M $10.00 Jul 28, 2023 Through DA32 Sponsor LLC
Twist Bioscience Corp Director Common Stock 76K $3.75M $49.35 Feb 5, 2025 By Keith L. Crandell Trust
Quanterix Corp Director Common Stock 131K $3.53M $26.91 Apr 3, 2023 Direct
Twist Bioscience Corp Director Common Stock 22.5K $1.11M $49.35 Feb 5, 2025 Direct
908 Devices Inc. Director, 10%+ Owner Common Stock 13.9K $89.4K $6.42 Jun 12, 2024 Direct
908 Devices Inc. Director, 10%+ Owner Stock Option (option to buy) 16K $28K $1.75 Jun 13, 2024 Direct
Boundless Bio, Inc. 10%+ Owner Common Stock 1.18M Apr 2, 2024 Indirect
Quanterix Corp Director Stock Option (Right to Buy) 12.1K Jan 3, 2023 Direct
908 Devices Inc. Director, 10%+ Owner Restricted Stock Unit 11.4K Jun 13, 2024 Direct
Boundless Bio, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Apr 2, 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Apr 2, 2024 Indirect
Boundless Bio, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 Apr 2, 2024 Indirect
DA32 Life Science Tech Acquisition Corp. Director, 10%+ Owner Class A Common Stock 0 $10.00 Jul 28, 2023 Through ARCH Venture Fund XI, L.P.

Insider Reports Filed by Keith Crandell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TWST Twist Bioscience Corp Feb 5, 2025 1 $0 4 Feb 7, 2025 Director
MASS 908 Devices Inc. Jun 12, 2024 4 $0 4 Jun 14, 2024 Director, 10%+ Owner
BOLD Boundless Bio, Inc. Apr 2, 2024 12 $3.2M 4 Apr 4, 2024 10%+ Owner
BOLD Boundless Bio, Inc. Mar 27, 2024 0 $0 3 Mar 27, 2024 10%+ Owner
SANA Sana Biotechnology, Inc. Feb 8, 2024 3 $10M 4 Feb 12, 2024 10%+ Owner
TWST Twist Bioscience Corp Feb 6, 2024 1 $0 4 Feb 9, 2024 Director
DALS DA32 Life Science Tech Acquisition Corp. Jul 28, 2023 1 $0 4 Aug 10, 2023 Director, 10%+ Owner
MASS 908 Devices Inc. Jun 14, 2023 4 $0 4 Jun 16, 2023 Director, 10%+ Owner
QTRX Quanterix Corp Apr 3, 2023 1 $13.1K 4 Apr 4, 2023 Director
TWST Twist Bioscience Corp Feb 7, 2023 1 $0 4 Feb 9, 2023 Director, 10%+ Owner
QTRX Quanterix Corp Jan 3, 2023 3 $13.1K 4 Jan 4, 2023 Director
QTRX Quanterix Corp Oct 3, 2022 1 $13.9K 4 Oct 5, 2022 Director
QTRX Quanterix Corp Jul 1, 2022 1 $15K 4 Jul 6, 2022 Director, 10%+ Owner
MASS 908 Devices Inc. Jun 15, 2022 4 $0 4 Jun 17, 2022 Director, 10%+ Owner
QTRX Quanterix Corp Apr 1, 2022 1 $15K 4 Apr 5, 2022 Director, 10%+ Owner
TWST Twist Bioscience Corp Feb 8, 2022 1 $0 4 Feb 10, 2022 Director
QTRX Quanterix Corp Jan 3, 2022 9 $13K 4 Jan 5, 2022 Director, 10%+ Owner
QTRX Quanterix Corp Oct 1, 2021 7 $13K 4 Oct 5, 2021 Director, 10%+ Owner
TWST Twist Bioscience Corp Aug 12, 2021 15 -$4.82M 4 Aug 13, 2021 Director
DALS DA32 Life Science Tech Acquisition Corp. Aug 5, 2021 1 $0 4 Aug 9, 2021 Director, 10%+ Owner
DALS DA32 Life Science Tech Acquisition Corp. Jul 30, 2021 2 $22.5M 4 Aug 3, 2021 Director, 10%+ Owner
DALS DA32 Life Science Tech Acquisition Corp. Jul 27, 2021 0 $0 3 Jul 27, 2021 Director, 10%+ Owner
QTRX Quanterix Corp Jul 1, 2021 10 $13K 4 Jul 6, 2021 Director
MASS 908 Devices Inc. Jun 17, 2021 2 $0 4 Jun 21, 2021 Director, 10%+ Owner
QTRX Quanterix Corp Apr 1, 2021 7 $13K 4/A Jul 6, 2021 Director